Charles River Laboratories (CRL) Holding Has Raised by National Investment Services Inc; Omnicom Group (OMC) Share Price Rose While Martingale Asset Management LP Trimmed Its Position by $2.03 Million

Omnicom Group Inc. (NYSE:OMC) Logo

Martingale Asset Management LP decreased its stake in Omnicom Group Inc (OMC) by 7.17% based on its latest 2018Q3 regulatory filing with the SEC. Martingale Asset Management LP sold 29,810 shares as the company’s stock rose 8.95% while stock markets declined. The institutional investor held 386,136 shares of the advertising company at the end of 2018Q3, valued at $26.27 million, down from 415,946 at the end of the previous reported quarter. Martingale Asset Management LP who had been investing in Omnicom Group Inc for a number of months, seems to be less bullish one the $17.15B market cap company. The stock increased 0.74% or $0.56 during the last trading session, reaching $76.51. About 1.93M shares traded. Omnicom Group Inc. (NYSE:OMC) has risen 3.76% since January 12, 2018 and is uptrending. It has outperformed by 3.76% the S&P500. Some Historical OMC News: 23/05/2018 – London Exchange: PRESS: WPP Loses USD400 Million HSBC Account To Omnicom – FT; 20/04/2018 – End of Sorrell’s reign heralds change for big ad empires; 09/04/2018 – Porter Novelli to Launch International Rescue Committee’s Displaced Podcast Series; 27/03/2018 – OMNICOM HEALTH GROUP – ACQUIRED UNIT’S MANAGEMENT TEAM ALSO JOINS EMC, WITH TAKAO OZAWA BEING PROMOTED TO MANAGING DIRECTOR; 12/04/2018 – OMNICOM TO COMBINE CHAIRMAN AND CEO ROLES; 26/04/2018 – Jenny Glover Joins Juniper Park\TBWA as Executive Creative Director; 16/05/2018 – The lnteger Group Announces Partnership with Argentina’s AVC Marketing; 03/05/2018 – FleishmanHillard Appoints Janise Murphy Chief Practice Officer; 07/03/2018 – FleishmanHillard Hires Research and Technology Strategist Matt Groch to Lead Development of Global Data Analytics Capability; 17/04/2018 – Ad firm Omnicom’s revenue rises 1.2 pct

National Investment Services Inc increased its stake in Charles River Laboratories (CRL) by 237.37% based on its latest 2018Q3 regulatory filing with the SEC. National Investment Services Inc bought 11,358 shares as the company’s stock rose 0.80% while stock markets declined. The institutional investor held 16,143 shares of the health care company at the end of 2018Q3, valued at $2.17M, up from 4,785 at the end of the previous reported quarter. National Investment Services Inc who had been investing in Charles River Laboratories for a number of months, seems to be bullish on the $5.73B market cap company. The stock decreased 0.32% or $0.38 during the last trading session, reaching $119.21. About 291,009 shares traded. Charles River Laboratories International, Inc. (NYSE:CRL) has risen 23.83% since January 12, 2018 and is uptrending. It has outperformed by 23.83% the S&P500. Some Historical CRL News: 08/03/2018 – ACELRX PHARMACEUTICALS INC – ACELRX PROPOSED POTENTIAL RESOLUTIONS FOR TWO MAIN POINTS IDENTIFIED IN CRL RECEIVED FROM FDA IN OCTOBER 2017; 10/05/2018 – Charles River Labs 1Q EPS $1.08; 26/03/2018 – CHARLES RIVER LABORATORIES – REFINANCED EXISTING $1 BLN OF REVOLVING CREDIT FACILITY DUE 2021 WITH NEW $1.55 BLN REVOLVING CREDIT FACILITY DUE 2023; 24/05/2018 – RECRO PHARMA INC – CRL RAISED CMC RELATED QUESTIONS ON EXTRACTABLE AND LEACHABLE DATA PROVIDED IN NDA; 09/04/2018 – CHARLES RIVER LABS, PATHOQUEST EXPAND STRATEGIC BIOLOGICS; 26/03/2018 – CHARLES RIVER LABS REPORTS REFINANCING OF CREDIT LINES &; 26/03/2018 – CHARLES RIVER REFINANCE $1B PACT WITH NEW $1.55B REVOLVING PACT; 24/05/2018 – Recro Pharma: CRL Raised CMC Related Questions on Extractable and Leachable Data Provided in the NDA; 10/04/2018 – Charles River Presenting at Conference Apr 16; 09/05/2018 – Lipocine: FDA CRL Identified Four Deficiencies

More notable recent Charles River Laboratories International, Inc. (NYSE:CRL) news were published by: Seekingalpha.com which released: “Goldman bearish on Walgreens Boots Alliance in premarket analyst action; shares down 4% premarket – Seeking Alpha” on December 14, 2018, also Businesswire.com with their article: “Charles River Laboratories Acquires Blue Stream Laboratories – Business Wire” published on June 27, 2016, Seekingalpha.com published: “AstraZeneca’s Mistakes Mount – Seeking Alpha” on March 21, 2017. More interesting news about Charles River Laboratories International, Inc. (NYSE:CRL) were released by: Seekingalpha.com and their article: “Charles River Labs: The Growth Is Real – Seeking Alpha” published on August 09, 2018 as well as Benzinga.com‘s news article titled: “Earnings Scheduled For November 7, 2018 – Benzinga” with publication date: November 07, 2018.

Since July 17, 2018, it had 0 buys, and 9 insider sales for $10.12 million activity. $428,690 worth of Charles River Laboratories International, Inc. (NYSE:CRL) was sold by FOSTER JAMES C. Kochevar Deborah Turner sold 4,066 shares worth $502,799. JOHST DAVID P also sold $3.18 million worth of Charles River Laboratories International, Inc. (NYSE:CRL) on Wednesday, November 7. The insider BERTOLINI ROBERT J sold 1,100 shares worth $148,179. Another trade for 3,978 shares valued at $476,962 was made by Girshick Birgit on Tuesday, July 17.

National Investment Services Inc, which manages about $4.22 billion and $101.89M US Long portfolio, decreased its stake in Dollar Tree Stores Inc. (NASDAQ:DLTR) by 5,595 shares to 34,830 shares, valued at $2.84M in 2018Q3, according to the filing. It also reduced its holding in Thermo Fisher Scientific Inc C (NYSE:TMO) by 1,517 shares in the quarter, leaving it with 12,241 shares, and cut its stake in National Beverage Corp. (NASDAQ:FIZZ).

Among 21 analysts covering Charles River Laboratories (NYSE:CRL), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Charles River Laboratories had 64 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of Charles River Laboratories International, Inc. (NYSE:CRL) earned “Buy” rating by Robert W. Baird on Tuesday, February 13. Bank of America maintained Charles River Laboratories International, Inc. (NYSE:CRL) on Friday, November 10 with “Buy” rating. As per Thursday, August 4, the company rating was maintained by Citigroup. The stock of Charles River Laboratories International, Inc. (NYSE:CRL) has “Buy” rating given on Thursday, August 9 by Jefferies. Wells Fargo upgraded the shares of CRL in report on Monday, October 12 to “Market Perform” rating. The company was maintained on Thursday, November 8 by Robert W. Baird. The stock has “Equal-Weight” rating by Morgan Stanley on Wednesday, March 14. Raymond James maintained the stock with “Outperform” rating in Thursday, November 8 report. Jefferies maintained Charles River Laboratories International, Inc. (NYSE:CRL) rating on Monday, April 24. Jefferies has “Buy” rating and $106 target. The firm earned “Buy” rating on Wednesday, January 4 by Evercore.

Investors sentiment decreased to 1.25 in 2018 Q3. Its down 0.18, from 1.43 in 2018Q2. It is negative, as 23 investors sold CRL shares while 102 reduced holdings. 55 funds opened positions while 101 raised stakes. 45.21 million shares or 6.76% less from 48.49 million shares in 2018Q2 were reported. 18,869 were reported by Globeflex Capital L P. Personal Capital Advisors invested 0.23% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL). Shine Inv Advisory Svcs holds 0.02% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL) for 343 shares. Metropolitan Life reported 0.04% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL). Panagora Asset Incorporated holds 0.1% or 194,200 shares. Wells Fargo Com Mn has 1.39 million shares. M&T Bank & Trust Corporation holds 0% or 4,008 shares in its portfolio. Keybank Association Oh holds 0% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL) for 3,073 shares. Company Retail Bank, a Missouri-based fund reported 10,032 shares. Natl Invest Inc Wi holds 16,143 shares or 2.13% of its portfolio. 22,430 were reported by Oak Assoc Oh. Utah Retirement accumulated 8,797 shares or 0.02% of the stock. New Mexico Educational Retirement Board stated it has 0.06% in Charles River Laboratories International, Inc. (NYSE:CRL). Trustees Of Dartmouth College reported 217 shares or 0.03% of all its holdings. Massachusetts Financial Service Ma invested in 248,911 shares.

Analysts await Omnicom Group Inc. (NYSE:OMC) to report earnings on February, 21. They expect $1.65 earnings per share, up 6.45% or $0.10 from last year’s $1.55 per share. OMC’s profit will be $369.77 million for 11.59 P/E if the $1.65 EPS becomes a reality. After $1.24 actual earnings per share reported by Omnicom Group Inc. for the previous quarter, Wall Street now forecasts 33.06% EPS growth.

Another recent and important Omnicom Group Inc. (NYSE:OMC) news was published by Gurufocus.com which published an article titled: “New Research: Key Drivers of Growth for Suncor Energy, Apollo Global Management, Fiat Chrysler Automobiles NV, Navient, TransCanada, and Omnicom Group — Factors of Influence, Major Initiatives and Sustained Production – GuruFocus.com” on December 28, 2018.

Since July 19, 2018, it had 0 insider purchases, and 6 insider sales for $1.14 million activity. Another trade for 200 shares valued at $14,006 was made by Hewitt Dennis E. on Friday, October 26. 533 shares were sold by RICE LINDA JOHNSON, worth $40,657 on Thursday, October 18.

Martingale Asset Management L P, which manages about $2.91 billion and $8.55 billion US Long portfolio, upped its stake in Pbf Energy Inc (NYSE:PBF) by 23,622 shares to 134,771 shares, valued at $6.73 million in 2018Q3, according to the filing. It also increased its holding in Heartland Finl Usa (NASDAQ:HTLF) by 6,300 shares in the quarter, for a total of 118,435 shares, and has risen its stake in Mallinckrodt Plc (NYSE:MNK).

Charles River Laboratories International, Inc. (NYSE:CRL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.